TTrialPathMatch Me to Trials
← Back to trials
RecruitingMinimally Invasive Surgical ProceduresAbnormal Uterine Bleeding, UnspecifiedAdenomyosis of Uterus

Cyclobenzaprine for Postoperative Pain in Minimally Invasive Hysterectomy

Eligible age

18+ yrs

Accepts

Women

Locations

1 state

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

Typical postoperative pain control after minimally invasive hysterectomy includes ibuprofen, acetaminophen, and a short course of narcotics. The purpose of this study is to see if adding cyclobenzaprine to this regime improves pain control and lessens narcotic use.

Sponsor: Christiana Care Health Services

You may qualify if…

  • ✓ Age \>18yo
  • ✓ Female
  • ✓ English speaking
  • ✓ Undergoing (robotic assisted or classic) total laparoscopic hysterectomy ± unilateral or bilateral salpingectomy ± unilateral or bilateral oophorectomy
  • ✓ If other procedures such as lysis of adhesions, excision of endometriosis, or ureterolysis are indicated based on intraoperative evaluation, those patients may still be included
  • ✓ Surgery took place at ChristianaCare Hospitals
  • ✓ No allergies or contraindications to standard of care post operative pain medications (acetaminophen, NSAIDs, narcotics) or cyclobenzaprine

You may not qualify if…

  • ✕ Age \<18yo
  • ✕ Male
  • ✕ Pregnant, breastfeeding
  • ✕ Non-English speaking
  • ✕ Primary procedures other than laparoscopic hysterectomy
  • ✕ Laparoscopic myomectomy
  • ✕ Laparoscopic resection of endometriosis
  • ✕ Laparoscopic unilateral or bilateral salpingectomy ± unilateral or bilateral oophorectomy ± unilateral or bilateral cystectomy without hysterectomy

Where it's recruiting

Delaware

Newark

Source: ClinicalTrials.gov · NCT07664956 · last updated 2026-11-20

Cyclobenzaprine for Postoperative Pain in Minimally Invasive Hysterect · TrialPath